526 related articles for article (PubMed ID: 33831476)
41. Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player?
Albeiroti S; Soroosh A; de la Motte CA
Biomed Res Int; 2015; 2015():790203. PubMed ID: 26583132
[TBL] [Abstract][Full Text] [Related]
42. Syndecans in heart fibrosis.
Lunde IG; Herum KM; Carlson CC; Christensen G
Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic targets for cardiac fibrosis: from old school to next-gen.
Travers JG; Tharp CA; Rubino M; McKinsey TA
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229727
[TBL] [Abstract][Full Text] [Related]
44. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
Hinz B; Lagares D
Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
[TBL] [Abstract][Full Text] [Related]
45. MiR-34a/miR-93 target c-Ski to modulate the proliferaton of rat cardiac fibroblasts and extracellular matrix deposition in vivo and in vitro.
Zhang C; Zhang Y; Zhu H; Hu J; Xie Z
Cell Signal; 2018 Jun; 46():145-153. PubMed ID: 29551367
[TBL] [Abstract][Full Text] [Related]
46. Pro-fibrotic effect of oxidized LDL in cardiac myofibroblasts.
Villa M; Cerda-Opazo P; Jimenez-Gallegos D; Garrido-Moreno V; Chiong M; Quest AF; Toledo J; Garcia L
Biochem Biophys Res Commun; 2020 Apr; 524(3):696-701. PubMed ID: 32033750
[TBL] [Abstract][Full Text] [Related]
47. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
48. Myofibroblast modulation of cardiac myocyte structure and function.
Nagaraju CK; Dries E; Gilbert G; Abdesselem M; Wang N; Amoni M; Driesen RB; Sipido KR
Sci Rep; 2019 Jun; 9(1):8879. PubMed ID: 31222006
[TBL] [Abstract][Full Text] [Related]
49. AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis.
Francisco J; Zhang Y; Nakada Y; Jeong JI; Huang CY; Ivessa A; Oka S; Babu GJ; Del Re DP
Sci Rep; 2021 May; 11(1):10553. PubMed ID: 34006931
[TBL] [Abstract][Full Text] [Related]
50. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells.
Tarbit E; Singh I; Peart JN; Rose'Meyer RB
Heart Fail Rev; 2019 Jan; 24(1):1-15. PubMed ID: 29987445
[TBL] [Abstract][Full Text] [Related]
51. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
[TBL] [Abstract][Full Text] [Related]
52. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
53. Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming.
Bektik E; Fu JD
Cells; 2019 Jul; 8(7):. PubMed ID: 31277520
[TBL] [Abstract][Full Text] [Related]
54. Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.
Nagaraju CK; Robinson EL; Abdesselem M; Trenson S; Dries E; Gilbert G; Janssens S; Van Cleemput J; Rega F; Meyns B; Roderick HL; Driesen RB; Sipido KR
J Am Coll Cardiol; 2019 May; 73(18):2267-2282. PubMed ID: 31072570
[TBL] [Abstract][Full Text] [Related]
55. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Jin D; Han F
J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
[TBL] [Abstract][Full Text] [Related]
56. EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling.
Su SA; Yang D; Wu Y; Xie Y; Zhu W; Cai Z; Shen J; Fu Z; Wang Y; Jia L; Wang Y; Wang JA; Xiang M
Circ Res; 2017 Sep; 121(6):617-627. PubMed ID: 28743805
[TBL] [Abstract][Full Text] [Related]
57. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
58. The Role of Myofibroblasts in Physiological and Pathological Tissue Repair.
Schuster R; Younesi F; Ezzo M; Hinz B
Cold Spring Harb Perspect Biol; 2023 Jan; 15(1):. PubMed ID: 36123034
[TBL] [Abstract][Full Text] [Related]
59. IL-1β suppresses TGF-β-mediated myofibroblast differentiation in cardiac fibroblasts.
Brønnum H; Eskildsen T; Andersen DC; Schneider M; Sheikh SP
Growth Factors; 2013 Jun; 31(3):81-9. PubMed ID: 23734837
[TBL] [Abstract][Full Text] [Related]
60. Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts.
Crawford JR; Haudek SB; Cieslik KA; Trial J; Entman ML
J Cardiovasc Transl Res; 2012 Dec; 5(6):749-59. PubMed ID: 22972312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
